source
- Parabilis raises $670M in record-setting Nasdaq debut to fund cancer drug developmentParabilis completed a $670 million initial public offering on the Nasdaq, establishing the largest biotech debut in the exchange’s history. The offering drew strong investor demand even as attenti…
- Beren Therapeutics secures $300 million to fund rare disease drug launch ahead of FDA reviewBeren Therapeutics announced it has raised $300 million in new financing to support the development and launch of its rare disease therapy. The funding arrives as the company prepares for an FDA d…